Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India · Delayed Price · Currency is INR 22.85
-0.39 (-1.68%)
Jun 12, 2026, 3:27 PM IST
Balaxi Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,261 | 865 | 3,254 | 5,049 | 5,387 | 3,516 | |
Market Cap Growth | -53.23% | -73.41% | -35.56% | -6.27% | 53.22% | -32.97% |
Enterprise Value | 1,692 | 1,042 | 2,966 | 4,955 | 5,305 | 3,491 |
Last Close Price | 22.85 | 15.67 | 63.92 | 99.19 | 106.07 | 70.23 |
PE Ratio | 87.88 | 61.06 | 12.98 | - | 11.72 | 7.38 |
PS Ratio | 0.47 | 0.32 | 1.11 | 2.09 | 1.60 | 1.26 |
PB Ratio | 0.51 | 0.35 | 1.40 | 2.51 | 2.95 | 3.11 |
P/TBV Ratio | 0.58 | 0.40 | 1.59 | 2.88 | 3.42 | 3.91 |
P/FCF Ratio | - | - | - | 120.99 | - | 12.20 |
P/OCF Ratio | - | - | - | 103.77 | 88.67 | 10.30 |
EV/Sales Ratio | 0.63 | 0.39 | 1.01 | 2.05 | 1.58 | 1.25 |
EV/EBITDA Ratio | 19.84 | 12.22 | 8.01 | 10.60 | 9.38 | 6.95 |
EV/EBIT Ratio | 26.55 | 16.34 | 8.40 | 11.10 | 9.68 | 7.02 |
EV/FCF Ratio | - | - | - | 118.73 | - | 12.11 |
Debt / Equity Ratio | 0.23 | 0.23 | 0.23 | 0.10 | 0.07 | 0.03 |
Debt / EBITDA Ratio | 6.76 | 6.76 | 1.44 | 0.42 | 0.24 | 0.07 |
Debt / FCF Ratio | - | - | - | 4.65 | - | 0.13 |
Net Debt / Equity Ratio | 0.17 | 0.17 | 0.06 | -0.21 | -0.08 | -0.03 |
Net Debt / EBITDA Ratio | 5.05 | 5.05 | 0.34 | -0.92 | -0.27 | -0.07 |
Net Debt / FCF Ratio | -1.04 | -1.04 | -0.23 | -10.34 | 2.17 | -0.13 |
Asset Turnover | 0.84 | 0.84 | 1.03 | 0.97 | 1.62 | 2.02 |
Inventory Turnover | 1.86 | 1.86 | 2.07 | 1.38 | 2.03 | 3.53 |
Quick Ratio | 2.42 | 2.42 | 2.81 | 2.21 | 1.54 | 0.58 |
Current Ratio | 4.05 | 4.05 | 4.45 | 3.88 | 3.64 | 2.23 |
Return on Equity (ROE) | 0.59% | 0.59% | 11.58% | -1.24% | 31.05% | 53.51% |
Return on Assets (ROA) | 1.23% | 1.23% | 7.76% | 11.21% | 16.46% | 22.51% |
Return on Invested Capital (ROIC) | 0.62% | 0.64% | 15.34% | -32.45% | 31.94% | 49.28% |
Return on Capital Employed (ROCE) | 2.30% | 2.30% | 13.80% | 21.90% | 29.40% | 43.90% |
Earnings Yield | 1.12% | 1.64% | 7.70% | -0.47% | 8.53% | 13.55% |
FCF Yield | -32.84% | -47.88% | -17.25% | 0.83% | -1.30% | 8.20% |
Dividend Yield | - | - | - | - | - | 0.14% |
Payout Ratio | - | - | - | - | 1.08% | - |
Buyback Yield / Dilution | 1.29% | 1.29% | -7.26% | -1.69% | -1.23% | - |
Total Shareholder Return | 1.29% | 1.29% | -7.26% | -1.69% | -1.23% | 0.14% |